V. Benoît

发表

Additive effect between NF-κB subunits and p53 protein for transcriptional activation of human p53 promoter

Vincent Bours, Marie-Paule Merville, M. Merville, 2000, Oncogene.

Evaluation of Original Dual Thromboxane A2 Modulators as Antiangiogenic Agents

V. Castronovo, V. Benoît, J. Dogné, 2006, Journal of Pharmacology and Experimental Therapeutics.

TNF-α Protects Human Primary Articular Chondrocytes from Nitric Oxide-Induced Apoptosis Via Nuclear Factor-κB

M. Merville, V. Bours, V. Benoît, 2002, Laboratory Investigation.

Peroxisome Proliferator-activated Receptor-γ1 Is Dephosphorylated and Degraded during BAY 11-7085-induced Synovial Fibroblast Apoptosis*

M. Merville, V. Bours, V. Benoît, 2006, Journal of Biological Chemistry.

NF-κB-dependent MnSOD expression protects adenocarcinoma cells from TNF-α-induced apoptosis

M. Merville, V. Bours, V. Benoît, 2002, Oncogene.

15-Deoxy-Δ12,14-prostaglandin J2 Inhibits Bay 11-7085-induced Sustained Extracellular Signal-regulated Kinase Phosphorylation and Apoptosis in Human Articular Chondrocytes and Synovial Fibroblasts*

M. Merville, V. Bours, V. Benoît, 2004, Journal of Biological Chemistry.

NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis.

M. Merville, V. Bours, V. Benoît, 2002, Oncogene.

Low daunomycin concentrations protect colorectal cancer cells from hypoxia-induced apoptosis

M. Merville, V. Bours, V. Benoît, 2005, Oncogene.

Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation.

M. Merville, V. Benoît, B. Masereel, 2003, Prostaglandins, leukotrienes, and essential fatty acids.

Identification of cytokine-induced nuclear factor-kappaB target genes in ovarian and breast cancer cells.

M. Merville, V. Bours, V. Benoît, 2002, Biochemical pharmacology.

Roles of nuclear factor-kappaB, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosis.

M. Merville, V. Bours, V. Benoît, 2000, The Journal of pharmacology and experimental therapeutics.

Nuclear factor-kappa B, cancer, and apoptosis.

M. Merville, V. Bours, V. Benoît, 2000, Biochemical pharmacology.

Roles of Nuclear Factor-k B , p 53 , and p 21 / WAF 1 in Daunomycin-Induced Cell Cycle Arrest and Apoptosis 1

M. Merville, V. Bours, V. Benoît, 2000 .

Regulation of HER-2 oncogene expression by cyclooxygenase-2 and prostaglandin E2

M. Merville, V. Bours, V. Benoît, 2004, Oncogene.

TNFα- and IKKβ-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKγ and NF-κB activation

M. Merville, V. Bours, V. Benoît, 2006 .

First and second generations of COX-2 selective inhibitors.

V. Benoît, J. Dogné, M. Frédérich, 2004, Mini reviews in medicinal chemistry.

Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB

P. Hainaut, M. Merville, V. Bours, 2006, Oncogene.

Caspase-8-dependent HER-2 cleavage in response to tumor necrosis factor alpha stimulation is counteracted by nuclear factor kappaB through c-FLIP-L expression.

M. Merville, V. Bours, V. Benoît, 2004, Cancer research.

TNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activation.

J. Piette, M. Merville, V. Bours, 2006, The Biochemical journal.

TNF-alpha protects human primary articular chondrocytes from nitric oxide-induced apoptosis via nuclear factor-kappaB.

M. Merville, V. Bours, V. Benoît, 2002, Laboratory investigation; a journal of technical methods and pathology.